GP2 received the International Main Prize in The Neuro-Irv and Helga Cooper Foundation Open Science Prizes for its transformative contributions to neuroscience. The prizes recognize projects, services, tools, and platforms that unlock the power of open science in neuroscience to advance research, innovation, and collaboration for the benefit of health and society.
Launched in 2019, GP2 has fostered a global collaborative network involving over 200 research cohorts from more than 60 unique global locations to accelerate the understanding of Parkinson’s disease genetics. By generating and sharing comprehensive genetic data from over 250,000 volunteer participants—including whole-genome sequencing for more than 10,000 individuals—GP2 has enabled groundbreaking research into genetic contributors to Parkinson’s. The program’s open science approach has already facilitated nearly 1,000 data access requests, empowering the scientific community to advance diagnosis, treatment, and global understanding of the disease.
GP2’s Andrew Singleton and Cornelis Blauwendraat (pictured above) accepted the award on behalf of GP2 at the Neuro-Irv and Helga Cooper Foundation Prize Ceremony during the Open Science in Action Symposium on November 7, 2024 in Montreal.
This recognition is not just for us (Andy/Cornelis) but for everyone who has poured their time, energy, and passion into GP2. It’s a testament to the power of collaboration and shared vision. We were honored to accept this on behalf of our team, and we look forward to what we’ll achieve together in the future.
Congratulations to fellow 2024 winners Mohamed Abdelhack of the Krembil Centre for Neuroinformatics, CAMH and Michelle Wang of The Neuro, McGill. Thank you to the Irv and Helga Cooper Foundation for sponsorship of The Neuro-Irv and Helga Cooper Foundation Open Science Prizes and to The Neuro’s Tanenbaum Open Science Institute (TOSI) for the organization of the awards.
